Imidazoles for vaginitis.
Lee Cr, McKenzie Ca, A Nobles
Abstract
Lee Cr, McKenzie Ca, A Nobles
Abstract
Vaginal candidiasis is a common infection in women for which several effective therapeutic agents are currently available. Clotrimazole and miconazole were introduced in 1975, and both recently became available over the counter. These imidazole agents have largely replaced nystatin as primary therapy because of greater antifungal activity and shorter treatment regimens, thereby enhancing patient compliance. The cost for these OTC regimens ranges from $12.00 to $24.00 for the patient.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Vaginal candidiasis is a common infection in women for which several effective therapeutic agents are currently available. Clotrimazole and miconazole were introduced in 1975, and both recently became available over the counter. These imidazole agents have largely replaced nystatin as primary therapy because of greater antifungal activity and shorter treatment regimens, thereby enhancing patient compliance. The cost for these OTC regimens ranges from $12.00 to $24.00 for the patient.
Key concepts: Clotrimazole, Miconazole, Nystatin, Vaginitis, Medicine, Antifungal, Vulvovaginal Candidiasis, Intensive care medicine